IL-32 induces the production of IL-17 in CD4+ T cells, and reciprocally IL-17 affects the expression of IL-32 in fibroblasts-like synoviocytes (FLSs) of RA patients [108]. Here, IL32 is linked to rheumatoid arthritis.